THE HUVER JOURNEY
A life shaped by illness became a commitment to better care. This is how that commitment is becoming a company, one milestone at a time.
EXPLORE THE JOURNEYLISTENING
Before the first agent, there were conversations. HUVER began by listening to clinicians and understanding the work around every patient.
Every useful answer starts with a better question.
Conducted structured field research to identify the clinical and operational problems worth solving.
BUILDING
Specialized agents became a medical intelligence engine. That foundation became HUVA Chat, giving clinicians a direct way to work with medical AI.
Started building the orchestration engine that became the foundation of HUVAgent, including specialized-agent coordination and the first product experience.
Completed the first clinician-facing HUVA service and established a direct medical AI experience for healthcare professionals.
Completed the first clinical-deployment solution and advanced evidence retrieval through HUVAgent Deep Search.
IN THE FIELD
A U.S. company and time inside American healthcare brought a clearer view of the workflows HUVA needed to support, from clinical questions to daily operations.
Research in Korea. Product development and healthcare conversations in the United States.
Established HUVER’s U.S. company as the legal foundation for its U.S.-led healthcare business and global expansion.
Visited healthcare sites and interviewed clinicians and healthcare professionals to understand local workflows, purchasing, and adoption requirements.
Received new investor review opportunities, discussed a clinical proof of concept with Stanford Medicine, and participated in NVIDIA GTC.
Entered the Texas Medical Center ecosystem in Houston for clinical validation, partnerships, and U.S. commercialization.
COMING TOGETHER
Work and Chat came together in one integrated platform. The next chapter is being shaped through product feedback and adoption work with U.S. clinics.
Completed the first integrated platform connecting organization-wide workflows with clinician-facing medical intelligence.
Following remote product briefings and live demonstrations, both clinics expressed their intent to proceed with adoption. Implementation planning and in-clinic workflow deployment are now underway.
Returned to the place where HUVER first shaped its U.S. expansion, now with a stronger product, a clearer plan, and relationships spanning a first Houston partner clinic and the TMC ecosystem.
Company milestones, September 2024 to August 2026, and the next planned release.
Conducted structured field research to identify the clinical and operational problems worth solving.
Secured technical instances through the Yonsei Graduate School of AI startup-support program and validated early agent architecture, orchestration, retrieval, and evaluation workflows.
Started building the orchestration engine that became the foundation of HUVAgent, including specialized-agent coordination and the first product experience.
Began Medical Multi-Agent AI research and developed a precision antibiotic-prescribing support sub-agent for a real clinical research setting.
Selected for the Preliminary Startup Package administered by Korea’s Ministry of SMEs and Startups.
Established a dedicated research and product-development environment in the Yonsei University startup ecosystem.
Established HUVER’s Korean entity and created the operating foundation for full-scale research, product, and business development.
Completed the first clinician-facing HUVA service and established a direct medical AI experience for healthcare professionals.
Joined the Global Startup Step-Up program to examine international healthcare workflows, market requirements, and expansion assumptions.
Entered global technology programs supporting cloud infrastructure, model development, technical guidance, and market readiness.
A Hybrid Multi-Agent for Precision Antibiotic Prescribing was accepted for presentation at the Korean Society of Infectious Diseases conference.
Established the first top-ranked performance milestone and a baseline for subsequent model improvement.
Completed the first clinical-deployment solution and advanced evidence retrieval through HUVAgent Deep Search.
Established HUVER’s U.S. company as the legal foundation for its U.S.-led healthcare business and global expansion.
Started building around the workflows of U.S. clinics, ASCs, and urgent care, including payer operations and human-controlled execution.
Visited healthcare sites and interviewed clinicians and healthcare professionals to understand local workflows, purchasing, and adoption requirements.
Ran an adoption pilot with U.S. clinics, observed real clinical and administrative workflows, and incorporated direct user feedback into product refinement.
Received new investor review opportunities, discussed a clinical proof of concept with Stanford Medicine, and participated in NVIDIA GTC.
Connected with healthcare-focused investment institutions through the Korea Health Industry Development Institute program.
Entered the Texas Medical Center ecosystem in Houston for clinical validation, partnerships, and U.S. commercialization.
Expanded access to NVIDIA’s technical ecosystem, expert support, and global AI network.
Completed HUVER’s corporate flip, establishing the Delaware C-Corp. as the parent company and the Korean entity as its subsidiary.
Completed the first integrated platform connecting organization-wide workflows with clinician-facing medical intelligence.
Following remote product briefings and live demonstrations, both clinics expressed their intent to proceed with adoption. Implementation planning and in-clinic workflow deployment are now underway.
Returned to the place where HUVER first shaped its U.S. expansion, now with a stronger product, a clearer plan, and relationships spanning a first Houston partner clinic and the TMC ecosystem.
The next release is planned for the second half of 2026, expanding connected clinical and operational workflows.
THE NEXT HORIZON
Our ambition reaches from the software clinicians use today to the intelligent hospitals of tomorrow. We build toward that future, one useful step at a time.
Future hospital concept